BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1305732)

  • 1. [Effect of ACE inhibitors on proteinuria and renal functioning in primary glomerulopathies].
    Boratyńska M; Mazanowska O; Szewczyk Z; Czyz W
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1090-2. PubMed ID: 1305732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
    Erley CM; Komini E; Nicaeus T; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1994 Jan; 119(4):89-95. PubMed ID: 8299527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
    Prasher PK; Varma PP; Baliga KV
    J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
    Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L; Renke M; Rutkowski P; Rutkowski B; Lysiak-Szydłowska W
    Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual renin-angiotensin system blockade: in patients with single functioning kidney and proteinuria.
    Robles NR; Ruiz Jiménez B; Hernández Gallego R; Ruiz-Calero R; Sánchez Casado E; Cubero JJ
    Eur J Intern Med; 2009 Mar; 20(2):186-9. PubMed ID: 19327610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
    Neverov NI; Stavrovskaia EV; Kolina IB; Shvetsov MIu; Zakharova EV; Shilov EM
    Ter Arkh; 2001; 73(6):37-40. PubMed ID: 11521519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
    Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B
    Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
    Masunaga Y; Tabei K; Takeda S; Ando Y; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
    Camacho Díaz JA; Giménez Llort A; García García L; Jiménez González R
    An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y; Kitamoto Y; Futaki G; Ueda H; Monma H; Ishizaki M; Takahashi H; Sekino H; Sasaki Y
    N Engl J Med; 1985 Dec; 313(26):1617-20. PubMed ID: 3906398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the angiotensin-converting enzyme inhibitor enalapril on the rates of progression of chronic kidney failure in patients with different degrees of functional kidney disorders].
    Esaian AM; Kaiukov IG; Titova VA
    Ter Arkh; 1995; 67(6):57-9. PubMed ID: 7667785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril: antiproteinuric effect in children with nephrotic syndrome.
    Lama G; Luongo I; Piscitelli A; Salsano ME
    Clin Nephrol; 2000 Jun; 53(6):432-6. PubMed ID: 10879662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B; Vajo Z; Dachman W
    Acta Physiol Hung; 1996; 84(4):361-7. PubMed ID: 9328608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment.
    Bianchini G; Letizia C; Domenici A; Scavo D
    Drugs Exp Clin Res; 1991; 17(5):263-9. PubMed ID: 1661665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.